Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Other Operating Expenses (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Other Operating Expenses readings, the most recent being $88000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 25.42% to $88000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $432000.0, a 33.33% increase, with the full-year FY2025 number at $432000.0, up 33.33% from a year prior.
  • Other Operating Expenses hit $88000.0 in Q4 2025 for Treace Medical Concepts, down from $92000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $23.3 million in Q4 2021 to a low of -$357000.0 in Q4 2022.
  • Median Other Operating Expenses over the past 5 years was $95500.0 (2023), compared with a mean of $3.3 million.
  • Biggest five-year swings in Other Operating Expenses: tumbled 101.53% in 2022 and later soared 6300.0% in 2023.
  • Treace Medical Concepts' Other Operating Expenses stood at $23.3 million in 2021, then tumbled by 101.53% to -$357000.0 in 2022, then soared by 126.89% to $96000.0 in 2023, then grew by 22.92% to $118000.0 in 2024, then dropped by 25.42% to $88000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $88000.0 (Q4 2025), $92000.0 (Q3 2025), and $122000.0 (Q2 2025) per Business Quant data.